Loading...
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study
BACKGROUND: Biomarkers are urgently needed to dissect the heterogeneity of prostate cancer between patients to improve treatment and accelerate drug development. We analysed blood mRNA expression arrays to identify patients with metastatic castration-resistant prostate cancer with poorer outcome. ME...
Na minha lista:
| Udgivet i: | Lancet Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4878433/ https://ncbi.nlm.nih.gov/pubmed/23059046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(12)70372-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|